You are using an older browser version. Please use a supported version for the best MSN experience.

January will be a huge month for these hard-hit stocks. Why now’s the time to load up on riskier names, says JPMorgan.

MarketWatch logo MarketWatch 12/27/2021 Barbara Kollmeyer
© Getty Images
NEED TO KNOW

Where we left off before Christmas? A record session for the S&P 500 and so-so action from tech stocks.


Video: It's Possible That BOE Hikes Today, Goldman Sachs Says (Bloomberg)

The Nasdaq is up a mere 0.7% this month, versus around a 3.5% rise for the S&P though on a year-to-date basis those gains are 21% and 25%, respectively. And with many traders perhaps taking the rest of the year off, that’s likely what we’ll get for the year.

Our call of the day comes from JPMorgan — one of the more bullish houses on Wall Street for the year ahead — which is advising investors to start snapping up riskier, or high-beta, stocks.

Driven by more hawkish central banks, the omicron coronavirus variant, forced deleveraging, poor year-end liquidity and general bearish sentiment, investors are “back to paying record premium” for low-volatility stocks, such as safe-haven and mega cap names. That has led to “sharp derisking and outright bear market” for higher-beta value and growth stocks, said a team led by the bank’s chief equity market strategist, Dubravko Lakos-Bujas.

“In particular, outside of the Big 10 stocks in the U.S., equity drawdowns and multiple derating have been severe,” he said, noting that the Russell 3000 is down just 4% and the Nasdaq 7% from 12-month highs. But the average drawdown for constituents in those indexes are down 28% and 38%, respectively.

“Some argue this price action is a harbinger of late-cycle dynamics or at least an intra-cycle 10-20% market correction. In our view, conditions for a large selloff are not in place right now given already low investor positioning, record buybacks, limited systematic amplifiers, and positive January seasonals,” said Lakos-Bujas.

As for the current worries dragging the high-beta stocks south, JPMorgan strategists said the “market has taken the hawkish central bank and bearish omicron narratives too far.” They don’t see the Fed as behind the curve, and expect inflation pressures to normalize in coming months and quarters, and they don’t see a big growth hit from the omicron variant.

“More so, performance in the hedge fund space has been poor lately with many giving back multiple quarters of gains. This resulted in forced liquidations and deleveraging at a time of low liquidity, triggering extreme stock price action, especially across the High Beta stock complex,” said the JPMorgan strategists.

Stocks they like in particular are on the value and cyclical side, such as travel, leisure, hospitality, experiences (some of which aren’t doing so well for Monday). On the secular growth side, they like payments, e-commerce, gaming, cybersecurity and biotech. These stocks have already be derated 30% to 70%, noted the strategists, who add that historical analysis shows that high-beta stocks tend to see the biggest outperformance in January, via investor bottom fishing and tax-loss harvesting, etc.

“We expect the upcoming ‘January effect’ to be even more pronounced this time around given extreme positioning and sentiment, with a potential for a large High Beta squeeze. Funding could come from increasingly crowded low vol. stocks where investors are again paying record premium for that shelter,” said Lakos-Bujas.

Here are a few recently crowded, top momentum stocks, now at a “significant discount,” highlighted by the bank: New Fortress Energy MasTec Plug Power Peloton Interactive Under Armour Macy’s Gap Moderna Novavax AMC and Pinterest

The buzz

White House medical adviser Dr. Anthony Fauci warned Sunday that Americans shouldn’t get complacent over the omicron variant, which could swamp hospitals with COVID-19 patients even if many infections appear mild.

That’s as thousands of flights were canceled across the globe over the weekend — shares of American Delta and United Airlines are falling in premarket — while holiday cruises are also getting complicated. Shares of Carnival are off nearly 4%.

Roche’s at-home COVID-19 tests, which can produce results in as little as 20 minutes, have been approved for U.S. emergency-use.

Travel may have taken an omicron hit, but steely shoppers drove the fastest pace of holiday sales in 17 years.

Sony and Marvel’s megahit, “Spider Man: No Way Home,” has become the third-fastest movie to gross $1 billion at the box office.

The markets

Stock futures are inching up, following a solid week for Wall Street. Asian markets were a mixed bag, and with London out for a holiday, Europe is fairly quiet. Oil prices are under pressure, likely not help by the mass holiday flight cancellations. The dollar is up and Treasury yields are steady.

The tickers

These are the most active tickers on MarketWatch as of 6 a.m. Eastern Time.

Ticker Asset
Tesla
AMC Entertainment
GameStop
Nio
U.S. Dollar Index
E-Mini S&P 500 Futures
U.S. 10-Year Treasury Note
Apple
Dow Jones Industrial Average
E-Mini Nasdaq 100 Index
Random reads

Maybe the best granny Christmas prank ever.

Large Roman fort dating back to AD43 unearthed near Amsterdam.

Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.

Want more for the day ahead? Sign up for The Barron’s Daily, a morning briefing for investors, including exclusive commentary from Barron’s and MarketWatch writers.

AdChoices
AdChoices
AdChoices

More from Marketwatch

image beaconimage beaconimage beacon